Did The Fourth Branch of Government Release SARS-CoV-2 Then Blame China?

So much research has been done, we essentially know the majority of the background details.  The SARS-CoV-2 virus commonly known as COVID-19 was made in a lab by scientists.  The virus then went from a lab to the global population in late 2019/early 2020.  The epicenter of the outbreak appears to be one of the labs working on the virus in Wuhan, China.  Those essential big picture items are no longer debated; although the Chinese government does not agree for obvious reasons.

With the ‘where’, ‘when’ and ‘how’ essentially agreed, the question of ‘who’ and ‘why’ remains.

The Chinese have blamed the U.S. Intelligence agencies for releasing the virus.  The U.S. Intelligence agencies have said they don’t know who released it or from where. [LINK] The U.S. Intelligence position is weird and obtuse, then again, the Intelligence Community specializes in being weird and obtuse.

The cornerstone of the CTH hypothesis, regarding the ‘who’ and ‘why’ of the COVID-19 virus, is built upon the intelligence communitie’s odd position and one very key circumstantial point that stands out loudly.   The U.S. Pentagon was funding the creation of SARS as a biological weapon in Wuhan, China, under the auspices of national security. “Grants from the Pentagon included $6,491,025 from the Defense Threat Reduction Agency (DTRA) from 2017 to 2020” (link).

 Central Point – The Defense Department would not be spending money to develop a biological weapon in Wuhan, China unless they already had developed that weapon in the United States.   The Pentagon would not give a biological weapon to the communist Chinese unless the U.S. already developed it; and unless they already had a countermeasure to the consequences of it.

In the original pdf guidance for the 2014 research pause of into weaponization of SARS viruses there was an important footnote [LINK]:

[FN¹  SOURCE – U.S. Government Gain-of-Function Deliberative Process and Research Funding Pause on Selected Gain-of-Function Research Involving Influenza, MERS, and SARS Viruses – pdf, page 2 – October 17, 2014]

Timeline:

 October 17, 2014 – U.S. funding of SARS to create a biological weapon was paused due to the extreme risk of a pandemic.  However, the pause allowed agencies within the U.S. government to continue funding if they determined “the research is urgently necessary to protect the public health or national security.” [LINK]

2014 through 2020 the Pentagon continued funding research in Wuhan, China. Fear of discovery would explain why many top officials in the U.S. Defense Department were against the Trump administration [with increased severity after the COVID pandemic began]. [LINK]

 May 2016 – [An Election Year] – “after thorough deliberation and extensive input from domestic and international stakeholders, the NSABB [National Science Advisory Board for Biosecurity] issued its recommendations. NSABB’s central finding was that studies that are expected to enhance Potential Pandemic Pathogen (PPP) have potential benefits to public health but also entail significant risks. NSABB recommended that such studies warranted additional scrutiny prior to being funded.”  Anthony Fauci is on the NSABB.

January 9, 2017 – [Four Days after the Susan Rice Oval Office meeting with Obama, Biden, Comey, et al] – The Obama Administration re-authorizes funding for the creation of SARS biological weapons.  “Adoption of these recommendations will satisfy the requirements for lifting the current moratorium on certain life sciences research that could enhance a pathogen’s virulence and/or transmissibility to produce a potential pandemic pathogen (an enhanced PPP).“ [LINK]

Given the workarounds, exceptions and plausible deniability for the consequences, built into the original moratorium guidance in 2014, the defense department was operationally permitted to keep funding the biological weapons research in Wuhan, China.  The 2014 ban was a funding moratorium in name only; however, it appears the funding for U.S. research in North Carolina was stopped.

What was reauthorized in 2017, just before President Trump took office, was the need to use “national security” as an excuse to continue the research.  It also appears funding of SARS as a biological weapon inside the U.S. (North Carolina) was now permitted again.

Read the Whole Article

The post Did The Fourth Branch of Government Release SARS-CoV-2 Then Blame China? appeared first on LewRockwell.

Leave a Comment